No definition available.
Neonatal jaundice from other and unspecified causes
P16_NEONTAL_JAUND_OTH_UNSP_CAUSES
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
558 |
4. Check minimum number of eventsNone |
558 |
5. Include endpointsNone |
558 |
6. Filter based on genotype QC (FinnGen only) |
497 |
Control definitions (FinnGen only)
- Control exclude
- P16_HAEMORRHAGIC_HAEMATOL_DISORD_FETUS_NEWBO
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- P[5-6]
- Name in latin
- Icterus neonatalis ex causis aliis et non specificatis
Similar endpoints
↥List of similar endpoints to
Neonatal jaundice from other and unspecified causes
based on the number of shared cases.
Similar with more cases:
- Haemorrhagic and haematological disorders of fetus and newborn
- Certain conditions originating in the perinatal period
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 54258 | 22632 | 31624 |
| Only index persons | 20837 | 8616 | 12221 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.79 | 0.65 | 0.88 |
| Only index persons | 0.40 | 0.32 | 0.47 |
| Median age at first event (years) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.01 | 0.01 | 0.01 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 497 | 259 | 238 |
| Unadjusted period prevalence (%) | 0.10 | 0.09 | 0.11 |
| Median age at first event (years) | 0.01 | 0.01 | 0.01 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 530
- Matched controls
- 5128
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
P59.9
ICD-10 Finland
Neonatal jaundice, unspecified
3866.4
307.7
320
*
P59.0
ICD-10 Finland
Neonatal jaundice associated with preterm delivery
+∞
229.1
205
*
P07.3
ICD-10 Finland
Other preterm infants
20.0
216.3
199
150
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
7.1
65.6
114
190
P07.11
ICD-10 Finland
Other low birth weight 1500-1999 g
10.6
28.1
32
31
P70.4
ICD-10 Finland
Other neonatal hypoglycaemia
5.5
25.6
53
102
P59.3
ICD-10 Finland
Neonatal jaundice from breast milk inhibitor
+∞
22.8
22
*
P07.12
ICD-10 Finland
Other low birth weight 2000-2499 g
5.8
17.0
32
56
P22.0
ICD-10 Finland
Respiratory distress syndrome of newborn
11.9
15.4
28
24
WX722
NOMESCO Finland
PEEP
4.0
14.4
42
107
P59.8
ICD-10 Finland
Neonatal jaundice from other specified causes
+∞
12.4
12
*
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
2.8
11.5
60
221
P70.0
ICD-10 Finland
Syndrome of infant of mother with gestational diabetes
4.4
9.9
25
57
602
Kela drug reimbursment
Children's severe malnutrition
2.7
8.4
47
179
P01.5
ICD-10 Finland
Fetus and newborn affected by multiple pregnancy
6.2
7.9
20
32
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
4.6
7.6
18
39
A03FA02
ATC
cisapride; oral, rectal
3.6
7.3
24
67
P22.8
ICD-10 Finland
Other respiratory distress of newborn
7.2
7.1
16
22
P07.10
ICD-10 Finland
Other low birth weight 1000-1499 g
8.7
6.9
14
16
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.8
6.8
125
758
WW805
NOMESCO Finland
Transfer from treating institution to lower-Level care, accompanied by paramedic/nurse
10.8
6.7
12
11
P00.0
ICD-10 Finland
Fetus and newborn affected by maternal hypertensive disorders
4.3
6.7
17
39
P22.1
ICD-10 Finland
Transient tachypnoea of newborn
2.9
6.6
31
108
WX882
NOMESCO Finland
High dependency care
1.9
6.6
83
447
P07.2
ICD-10 Finland
Extreme immaturity
8.6
6.4
13
15
A11JC
ATC
Vitamins, other combinations
6.1
6.3
16
26
JKD50
NOMESCO Finland
Hepatoportoenterostomy
10.8
6.2
11
10
Q44.29
ICD-10 Finland
Atresia of bile ducts
10.8
6.2
11
10
P55.1
ICD-10 Finland
ABO isoimmunization of fetus and newborn
+∞
6.2
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
40
163
2.49
6.30
11.5
5.7
18.89
13.94
umol/l
0.48
40
146
35
153
2.30
4.77
10.3
6.0
100.37
95.84
%
0.46
35
153
35
153
2.30
4.77
4.2
2.6
—
—
—
0
0
92
569
1.68
4.58
19.9
8.4
9.82
5.88
umol/l
0.59
86
478
189
1415
1.45
3.97
20.8
9.7
47.58
24.99
umol/l
3.55
181
1306
19
84
2.23
2.60
7.6
5.4
—
—
—
0
0
17
73
2.29
2.49
1.1
1.3
8.75
4.03
u/ml
—
8
36
8
22
3.56
2.29
1.6
3.5
58.00
29.27
u/l
—
8
22
19
89
2.11
2.29
3.4
2.4
—
—
—
0
0
33
188
1.74
2.26
17.4
13.1
195.50
517.14
iu/ml
—
6
28
92
672
1.39
2.11
8.3
6.3
1.14
2.08
mg/l
1.65
69
489
20
100
1.97
2.05
1.5
1.6
—
—
—
0
0
66
458
1.45
2.01
12.9
12.3
97.55
91.99
%
1.37
66
458
17
81
2.06
1.98
1.0
1.1
—
—
—
0
0
16
75
2.10
1.94
1.1
1.3
12.40
3.23
u/ml
—
10
44
15
74
1.99
1.62
1.3
1.6
—
—
—
0
0
56
397
1.41
1.55
10.2
7.1
268.27
282.21
umol/l
0.56
56
381
5
15
3.25
1.47
5.8
2.0
—
—
—
0
0
12
58
2.03
1.38
3.1
1.9
—
—
—
0
0
31
201
1.52
1.36
2.1
1.4
—
—
—
0
0
31
201
1.52
1.36
2.1
1.4
—
—
—
0
0
53
382
1.38
1.36
2.5
2.2
130.41
165.15
u/ml
0.56
30
164
21
124
1.66
1.34
2.3
1.3
342.36
377.59
ug/g
0.34
14
68
40
275
1.44
1.33
3.1
2.6
85.20
92.54
au/ml
0.15
15
125
9
170
0.50
1.31
2.7
2.8
—
—
—
0
0
26
164
1.56
1.29
2.4
1.6
—
—
—
0
0
12
60
1.96
1.28
1.8
1.7
—
—
—
0
0
8
35
2.23
1.24
1.4
1.4
—
—
—
0
0
11
54
1.99
1.23
1.3
1.6
—
—
—
0
0
453
4218
1.27
1.14
25.6
18.5
13.28
13.10
%
1.99
444
4164
5
20
2.43
1.11
1.2
1.4
3.89
4.30
mg/l
—
5
15
11
57
1.89
1.08
2.1
1.7
132.64
126.74
%
0.13
11
57
118
982
1.21
1.02
3.8
3.8
6.37
6.78
e6/l
0.11
106
878
418
3873
1.21
1.01
15.0
10.3
26.71
25.00
u/l
0.90
411
3755
34
241
1.39
1.00
2.3
1.8
—
—
—
0
0
0
31
0.00
0.95
0.0
2.1
—
—
—
0
0
9
49
1.79
0.95
1.1
1.1
—
—
—
0
0
6
114
0.50
0.95
1.7
1.7
—
—
—
0
0
324
2948
1.16
0.93
16.5
12.6
3.31
3.33
e9/l
0.05
265
2399
255
2283
1.16
0.91
10.2
6.2
150.45
134.53
u/l
1.62
247
2156
104
870
1.19
0.86
3.0
2.9
0.00
0.00
estimate
-0.00
35
253
18
252
0.68
0.84
1.4
1.7
—
—
—
0
0
232
2414
0.88
0.80
2.8
2.4
5.22
5.29
mmol/l
0.59
212
2210
0
23
0.00
0.79
0.0
2.2
—
—
—
0
0
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
6
32
1.82
0.79
2.0
1.1
—
—
—
0
0
15
95
1.54
0.78
2.7
1.6
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
11
64
1.68
0.78
2.3
1.8
118.64
124.55
%
0.14
11
64
204
2138
0.88
0.77
2.1
2.0
2.76
3.76
u/ml
0.47
37
372
21
144
1.43
0.77
1.9
1.8
3.30
4.18
umol/l
0.88
21
127
6
33
1.77
0.76
2.0
1.1
—
—
—
0
0
84
698
1.20
0.76
21.5
16.1
0.81
0.81
mmol/l
0.15
84
676
14
88
1.55
0.75
1.1
1.2
—
—
—
0
0
25
178
1.38
0.75
1.5
1.4
—
—
—
0
0
29
212
1.34
0.74
2.8
2.0
—
—
—
0
0
145
1264
1.15
0.73
4.3
3.7
2.46
2.51
mg/l
0.14
132
1144
25
179
1.37
0.73
2.4
2.0
—
—
—
0
0
20
138
1.42
0.71
2.3
1.8
—
—
—
0
0
11
66
1.63
0.71
8.0
9.2
6.04
5.42
pmol/l
0.25
11
66
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
66
1.63
0.71
1.5
1.2
—
—
—
0
0
9
56
1.56
0.70
1.0
1.1
—
—
—
0
0
211
1892
1.13
0.69
3.9
3.9
0.00
0.00
estimate
-0.00
41
327
114
980
1.16
0.69
4.6
4.5
3.60
2.46
e6/l
0.53
59
526
262
2384
1.13
0.67
4.3
4.0
730.22
238.42
e6/l
—
9
26
12
75
1.56
0.67
4.8
7.6
5.11
4.84
kpa
0.42
12
75
30
225
1.31
0.66
37.1
27.3
0.71
0.70
%
0.06
30
225
10
60
1.62
0.65
1.1
1.1
—
—
—
0
0
38
452
0.80
0.64
1.3
1.2
11.43
14.65
iu/ml
—
10
77
77
646
1.18
0.64
1.5
1.5
258.91
416.61
u/ml
0.50
69
609
30
227
1.30
0.63
37.1
27.2
97.08
95.51
%
2.21
30
227
211
1903
1.12
0.62
3.9
3.9
0.00
3.89
estimate
0.50
42
316
31
237
1.28
0.61
3.1
2.2
—
—
—
0
0
8
49
1.59
0.61
17.8
8.8
1.25
1.23
mmol/l
—
8
43
6
34
1.72
0.57
1.5
1.8
—
—
—
0
0
43
345
1.22
0.57
1.0
1.0
8.16
8.77
mu/l
0.33
36
298
32
249
1.26
0.56
3.9
2.3
—
—
—
0
0
85
924
0.87
0.55
1.8
1.6
92.95
98.39
pmol/l
0.61
43
473
252
2309
1.11
0.54
16.5
10.5
5.95
5.96
mmol/l
0.02
241
2202
6
37
1.58
0.54
2.5
1.9
—
—
—
0
0
14
96
1.42
0.54
1.2
1.3
68.64
77.08
%
0.44
14
96
6
38
1.53
0.52
1.0
1.3
—
—
—
0
0
173
1557
1.11
0.52
5.4
5.0
18.35
23.20
e6/l
0.23
129
1155
11
72
1.49
0.52
2.8
1.4
—
—
—
0
0
111
974
1.13
0.52
4.6
4.3
0.75
0.84
e6/l
0.15
54
515
210
1911
1.10
0.51
3.9
3.9
0.00
0.00
estimate
-0.00
41
320
25
191
1.28
0.51
2.5
1.9
—
—
—
0
0
46
521
0.84
0.50
4.7
4.3
425.39
1183.42
ng/l
2.59
26
298
12
162
0.71
0.50
3.3
2.1
31.00
32.74
%
—
7
128
70
598
1.15
0.48
3.1
2.2
—
—
—
0
0
27
210
1.26
0.48
2.8
3.7
0.19
0.12
e6/l
0.31
27
201
46
519
0.84
0.48
2.7
2.3
10.35
51.84
ng/l
1.49
22
181
15
107
1.37
0.48
1.6
1.5
—
—
—
0
0
200
2050
0.91
0.47
1.9
1.8
1.33
1.44
g/l
0.74
103
1069
98
859
1.13
0.47
3.2
3.7
0.00
0.00
estimate
-0.00
40
307
36
414
0.83
0.47
1.3
1.2
2.10
9.05
u/ml
1.05
11
113
11
74
1.45
0.47
1.6
1.2
—
—
—
0
0
209
2137
0.91
0.47
4.2
3.4
34.60
35.24
mmol/mol
0.42
199
2033
7
47
1.45
0.46
2.4
2.4
—
—
—
0
0
53
445
1.17
0.46
3.0
2.4
7283.20
9719.94
u/l
—
10
114
22
168
1.28
0.46
2.0
2.0
—
—
—
0
0
22
168
1.28
0.46
2.2
2.3
—
—
—
0
0
33
265
1.22
0.46
1.3
1.4
—
—
—
0
0
174
1579
1.10
0.44
5.2
5.3
—
—
—
0
0
70
604
1.14
0.43
1.3
1.4
22.47
18.62
nmol/l
1.45
62
540
5
31
1.57
0.42
1.0
1.2
207.00
235.95
iu/ml
—
5
31
208
1908
1.09
0.42
11.8
5.2
33.09
25.71
u/l
1.36
195
1834
17
127
1.30
0.42
6.0
6.0
3.75
2.11
ug/l
1.37
17
127
13
93
1.36
0.41
1.2
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
7.6
—
3.85
—
0
15
15
188
0.77
0.41
1.3
1.3
—
—
—
0
0
10
68
1.43
0.41
1.6
1.2
—
—
—
0
0
10
68
1.43
0.41
1.2
1.1
—
—
—
0
0
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
7
99
0.68
0.40
1.0
1.0
1.50
1.47
g/l
—
7
99
39
324
1.18
0.40
2.8
1.8
2.42
2.42
mmol/l
0.09
34
270
10
69
1.41
0.38
1.2
1.1
—
—
—
0
0
10
69
1.41
0.38
1.2
1.1
—
—
—
0
0
407
4022
0.91
0.38
14.6
11.6
54.11
56.15
umol/l
1.23
402
3948
9
65
1.35
0.38
1.1
1.0
—
—
—
0
0
56
481
1.14
0.38
24.2
18.2
107.32
105.79
mmol/l
2.29
56
481
59
509
1.14
0.38
3.1
2.2
—
—
—
0
0
8
109
0.71
0.37
1.0
1.9
23.10
6.15
ug/l
—
8
102
11
78
1.37
0.37
9.2
3.5
—
—
—
0
0
11
78
1.37
0.37
9.2
3.5
—
—
—
0
0
50
427
1.15
0.37
2.9
2.5
4.87
6.50
iu/l
0.95
31
255
385
3811
0.92
0.37
24.7
16.1
139.34
139.43
mmol/l
0.38
374
3717
159
1451
1.09
0.36
5.4
4.9
0.84
0.20
e6/l
0.71
112
1048
35
291
1.18
0.36
33.8
21.9
5.21
5.39
kpa
0.66
35
283
35
291
1.18
0.36
33.8
21.9
15.89
15.80
kpa
0.03
35
283
10
70
1.39
0.36
1.2
1.1
—
—
—
0
0
20
157
1.24
0.35
5.8
10.6
24.71
23.85
mmol/l
0.56
20
147
18
140
1.25
0.34
1.3
1.6
—
—
—
0
0
15
114
1.28
0.34
1.1
1.4
4.34
4.67
mg/l
—
8
73
10
71
1.37
0.33
1.2
1.1
—
—
—
0
0
106
956
1.09
0.32
5.2
4.2
—
—
—
0
0
10
72
1.35
0.31
1.7
1.4
—
—
—
0
0
118
1216
0.92
0.31
16.6
11.5
5.00
5.18
kpa
0.63
118
1187
43
369
1.14
0.31
1.4
1.5
—
—
—
0
0
26
214
1.18
0.31
1.7
1.6
14.80
5.62
u/ml
0.29
19
151
7
97
0.69
0.31
5.4
5.1
15.71
20.10
index
—
7
88
80
716
1.10
0.29
1.1
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
12
146
0.79
0.28
25.8
28.0
0.33
0.33
iu/ml
—
5
95
8
62
1.25
0.27
3.5
5.5
28.15
25.49
ug/l
—
8
62
8
62
1.25
0.27
1.0
1.0
—
—
—
0
0
8
63
1.23
0.27
4.0
7.6
—
—
—
0
0
10
74
1.31
0.27
1.2
1.1
—
—
—
0
0
58
514
1.10
0.26
1.2
1.2
1.11
1.16
u/ml
0.03
41
372
14
165
0.82
0.26
4.4
4.1
3.37
9.23
index
—
8
112
43
375
1.12
0.25
2.2
2.6
23.03
28.28
u/l
1.51
34
295
9
72
1.21
0.25
2.1
1.6
—
—
—
0
0
9
73
1.20
0.25
1.7
1.4
—
—
—
0
0
115
1174
0.93
0.25
2.7
2.5
—
—
—
0
0
123
1252
0.94
0.24
16.5
11.8
5.79
5.79
kpa
0.02
123
1221
57
507
1.10
0.24
3.2
2.3
—
—
—
0
0
387
3806
0.94
0.23
24.4
16.1
3.95
3.94
mmol/l
0.30
376
3687
31
266
1.14
0.23
1.0
1.0
2.86
3.24
kpa
1.08
25
220
5
36
1.35
0.23
1.6
1.4
—
—
—
0
0
131
1208
1.07
0.23
2.8
3.1
0.00
0.00
estimate
0.50
32
254
119
1210
0.94
0.23
2.9
2.7
—
—
—
0
0
7
88
0.77
0.22
5.4
5.2
1.29
0.65
index
—
7
88
328
3238
0.95
0.22
4.5
3.6
14.33
14.48
pmol/l
0.56
298
2906
362
3564
0.95
0.22
4.8
4.1
2.07
2.04
mu/l
0.15
342
3390
217
2035
1.05
0.22
3.7
2.9
1.09
1.06
mmol/l
0.30
209
1939
104
954
1.07
0.22
2.4
2.9
1.02
1.02
kg/l
0.61
58
583
150
1393
1.06
0.21
5.4
4.1
—
—
estimate
—
0
0
0
11
0.00
0.21
0.0
1.4
—
48.09
—
0
11
5
41
1.18
0.21
1.0
1.1
314.80
283.63
mg/l
—
5
41
8
99
0.78
0.21
1.5
1.8
—
—
—
0
0
51
455
1.09
0.21
2.9
2.5
4.43
5.22
u/l
0.38
29
252
123
1245
0.94
0.21
16.1
11.8
0.89
0.94
mmol/l
0.07
109
1004
0
13
0.00
0.20
0.0
13.4
—
—
—
0
0
6
46
1.26
0.20
6.2
5.9
190.17
134.26
umol/l
—
6
23
31
270
1.12
0.19
1.0
1.0
-1.88
-2.43
mmol/l
—
8
68
31
270
1.12
0.19
1.0
1.0
7.59
7.31
kpa
0.42
25
223
58
523
1.08
0.19
1.2
1.2
4.54
6.30
u/ml
0.61
43
399
286
2708
1.05
0.19
5.9
4.8
6.78
6.84
mm/h
0.04
269
2554
61
554
1.07
0.17
1.3
1.3
3.08
2.97
u/ml
0.03
47
402
5
67
0.72
0.17
5.4
10.2
—
3738.83
—
0
12
8
66
1.18
0.16
8.0
2.3
28.44
23.63
mg/l
—
8
42
29
255
1.11
0.16
2.4
3.0
5.16
5.16
pmol/l
0.00
29
238
6
74
0.78
0.15
1.0
1.1
4.16
0.69
u/ml
—
6
74
104
966
1.05
0.15
2.2
2.1
1.18
1.19
mmol/l
0.06
99
906
41
426
0.93
0.15
10.5
9.7
1324.12
1343.51
ng/l
0.01
33
367
33
346
0.92
0.15
1.8
1.8
—
—
—
0
0
225
2131
1.04
0.14
26.4
17.4
1.23
1.23
mmol/l
0.36
217
2047
240
2368
0.96
0.14
5.0
3.9
50.21
48.10
ug/l
0.11
231
2272
13
109
1.16
0.13
2.2
1.8
3.12
3.56
iu/l
—
5
46
22
193
1.11
0.13
31.6
20.4
64.86
70.36
%
0.55
22
193
14
119
1.14
0.12
2.5
1.7
0.35
0.22
nmol/l
—
9
90
239
2353
0.97
0.12
2.1
2.2
—
—
—
0
0
497
4786
1.08
0.12
26.9
19.3
276.57
274.20
e9/l
0.30
479
4543
15
129
1.13
0.11
1.4
1.4
—
—
—
0
0
42
428
0.95
0.10
1.4
1.3
176.84
163.44
u/ml
0.08
17
107
5
44
1.10
0.09
1.6
2.0
2.52
1.85
mg/l
—
5
38
5
44
1.10
0.09
1.6
2.0
0.79
2.98
mg/l
—
5
37
5
44
1.10
0.09
1.6
2.0
2.22
4.00
mg/l
—
5
31
5
44
1.10
0.09
1.6
2.0
0.81
1.19
mg/l
—
5
38
5
44
1.10
0.09
1.6
2.0
4.28
5.91
mg/l
—
5
35
5
44
1.10
0.09
1.6
2.0
0.75
1.13
mg/l
—
5
33
5
44
1.10
0.09
1.6
2.0
0.80
1.10
mg/l
—
5
35
5
44
1.10
0.09
1.6
2.0
0.37
2.45
mg/l
—
5
36
497
4789
1.07
0.09
26.8
19.2
4.64
4.62
e12/l
0.24
477
4534
5
45
1.08
0.09
1.6
2.0
0.50
1.28
mg/l
—
5
37
34
310
1.07
0.09
1.1
1.1
1.25
0.88
u/ml
0.12
23
162
131
1238
1.03
0.09
19.2
10.8
0.97
0.74
mmol/l
0.43
99
911
497
4790
1.06
0.09
30.3
21.2
39.69
40.12
%
0.25
492
4729
77
721
1.04
0.09
1.3
1.3
—
7.92
—
0
6
6
52
1.12
0.09
1.0
1.1
—
—
—
0
0
5
58
0.83
0.08
6.6
2.6
0.79
1.58
ug/l
—
5
53
24
217
1.07
0.08
1.3
1.2
3.03
2.92
mmol/l
0.19
12
127
233
2284
0.98
0.08
3.8
3.2
4.16
4.23
mmol/l
0.66
223
2190
7
63
1.08
0.08
2.4
1.6
—
—
—
0
0
16
168
0.92
0.07
2.6
2.3
1.21
0.42
nmol/l
0.72
16
152
8
76
1.02
0.07
1.3
1.1
—
—
—
0
0
7
78
0.87
0.07
1.4
1.3
—
—
—
0
0
7
78
0.87
0.07
1.1
1.3
0.11
1.79
u/ml
—
7
78
8
90
0.86
0.07
1.3
2.6
—
7.12
—
0
38
54
505
1.04
0.06
1.2
1.2
8.51
3.41
u/ml
1.10
43
375
9
100
0.87
0.06
1.2
1.1
0.86
0.82
g/l
—
9
100
9
101
0.86
0.06
1.3
1.4
13.19
13.77
u/ml
—
9
92
29
267
1.05
0.06
24.7
16.8
0.53
0.61
%
0.92
29
267
190
1861
0.98
0.06
5.1
4.2
69.20
67.19
nmol/l
0.52
178
1777
32
296
1.05
0.06
27.0
17.7
123.44
126.49
g/l
0.32
32
289
217
2122
0.98
0.05
10.1
6.8
115.19
114.64
ml/min/173m2
0.16
142
1466
20
182
1.07
0.05
6.2
3.8
239.93
191.31
e6/l
0.38
14
117
17
154
1.07
0.05
9.6
11.7
48.05
61.88
%
1.49
17
149
29
269
1.05
0.04
1.4
1.3
3.17
3.18
ratio
0.01
18
168
25
231
1.05
0.04
1.3
1.3
—
—
—
0
0
35
327
1.04
0.04
1.2
1.2
6.61
11.76
u/ml
0.82
25
215
441
4253
1.02
0.03
19.1
12.9
23.16
24.09
mg/l
0.21
315
3030
27
251
1.04
0.03
2.1
1.8
—
—
—
0
0
11
98
1.09
0.03
1.6
1.7
—
—
—
0
0
10
105
0.92
0.03
1.2
1.5
44.30
63.14
ug/l
—
10
105
39
387
0.97
0.02
1.3
1.2
—
—
—
0
0
16
163
0.95
0.02
1.4
1.3
—
—
—
0
0
88
841
1.01
0.02
2.2
2.6
—
—
—
0
0
20
201
0.96
0.02
1.1
1.3
232.06
206.43
miu/ml
—
9
86
20
201
0.96
0.02
1.9
1.6
0.16
0.19
mg/l
—
8
76
232
2237
1.01
0.01
3.6
3.1
2.52
2.54
mmol/l
0.20
223
2128
79
770
0.99
0.00
2.1
2.4
—
—
—
0
0
230
2231
1.00
0.00
23.4
15.1
1.23
1.23
mmol/l
0.58
214
2092
19
179
1.03
0.00
6.1
3.8
966.38
536.41
e6/l
1.67
13
115
36
347
1.00
0.00
1.2
1.2
6.96
7.58
u/ml
0.06
27
234
20
192
1.01
0.00
7.0
4.9
2.50
7.91
e6/l
0.70
14
129
20
192
1.01
0.00
7.0
4.9
502.93
937.03
e6/l
0.26
14
132
24
228
1.02
0.00
1.8
1.9
—
—
—
0
0
448
4335
1.00
0.00
4.2
3.9
—
—
—
0
0
13
128
0.98
0.00
1.8
1.6
—
—
—
0
0
13
126
1.00
0.00
1.0
1.2
—
—
—
0
0
12
121
0.96
0.00
1.0
1.1
—
—
—
0
0
230
2229
1.00
0.00
3.6
3.1
1.35
1.39
mmol/l
1.04
220
2122
13
121
1.04
0.00
1.5
1.4
—
—
—
0
0
41
393
1.01
0.00
1.3
1.3
—
—
—
0
0
19
181
1.02
0.00
6.9
4.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
2.2
—
11.56
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
2.6
—
3.18
—
0
5
0
5
0.00
0.00
0.0
24.2
—
—
—
0
0
0
5
0.00
0.00
0.0
2.2
—
4.82
—
0
5
0
5
0.00
0.00
0.0
4.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
6
57
1.02
0.00
1.2
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
5
49
0.99
-0.00
1.2
1.2
102.40
121.94
pmol/l
—
5
49
8
77
1.01
-0.00
1.3
1.1
35.94
32.51
iu/ml
—
8
77
0
7
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
1.49
—
0
6
5
54
0.89
-0.00
3.2
9.7
—
—
—
0
0
6
58
1.00
-0.00
22.0
3.9
4.57
4.97
kpa
—
6
58
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
64
0.91
-0.00
1.0
3.0
16.67
19.28
u/ml
—
6
53
5
53
0.91
-0.00
1.0
1.7
11.56
8.08
umol/l
—
5
53
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
3.6
—
93.50
—
0
8
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint P16_NEONTAL_JAUND_OTH_UNSP_CAUSES and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| P16_NEONTAL_JAUND_OTH_UNSP_CAUSES | 0.886 [0.66, 1.18] | 0.414 |
| Birth year | 0.992 [0.98, 1.0] | 0.071 |
During the follow-up period (1.1.1998 — 31.12.2019), 56 out of 21667 females with P16_NEONTAL_JAUND_OTH_UNSP_CAUSES died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| P16_NEONTAL_JAUND_OTH_UNSP_CAUSES | 1.62 [1.3, 2.02] | < 0.001 |
| Birth year | 0.984 [0.97, 0.99] | 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 98 out of 30217 males with P16_NEONTAL_JAUND_OTH_UNSP_CAUSES died.
Mortality risk
Mortality risk for people of age
years, who have P16_NEONTAL_JAUND_OTH_UNSP_CAUSES.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.074% | 0.285% |
| 5 | 0.496% | 1.797% |
| 10 | 1.153% | 4.374% |
| 15 | 2.246% | 8.121% |
| 20 | 4.072% | 13.464% |
Relationships between endpoints
↥Index endpoint: P16_NEONTAL_JAUND_OTH_UNSP_CAUSES – Neonatal jaundice from other and unspecified causes
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data